Posts
Retail investors better to open their eyes before it's all too late & FOMO kicks in hard..
NFE, as thorough of a DD I could pull together now that my interest has been reignited with Blackrocks Q4 common stock purchase
$SOPA: The AI Pivot You Missed? 25% Short Interest + $8.8M AI Data Center Play 🚀
Listen up. While everyone is chasing old runners, Society Pass ($SOPA) just dropped a massive catalyst that the shorts haven't accounted for yet. We are looking at a micro-cap with a tiny float, high short interest, and a fresh entry into the AI infrastructure sector. The "Squeeze" Numbers: • Short …
AEHL bouncing at 52-week lows, high CTB, known runner
Price is sitting right at 52-week lows. After the last major run, it’s been in a long bleed and now looks like it’s trying to move up. Last major runs approached $4 and $3 respectively China runners are abound this week This play fits theme Low float. Low borrow
$AMCI - Robotics Name, 70% Insider Locked Til Feb 250% APR Cost To Borrow.
[$AMCI](https://x.com/search?q=%24AMCI&src=cashtag_click) is a really interesting Robotics IPO, I feel a lot of us are aware that like the quantum theme there will be a huge Robotic surge at some point. The problem is publicly traded companies are few and far between. So after a lot of digging I found AMC …
SqueezeFinder - Jan 23rd 2026
https://preview.redd.it/ldk35qozz3fg1.png?width=2104&format=png&auto=webp&s=5865cdaf11219a5f4fa0cf42072eb0d6f30d704d Good morning, SqueezeFinders! The $QQQ tech index closed yesterday at 620.76 (+0.73%), which leaves us onde again smack dab in the middle between the lower pivot at 613 and the upper pivot at 627/629. If the bullish recovery continues at the current pace, we could see a push back …
Bctx could there be a squeeze coming no shares high ctb 178%1.2 to 1.6 dtc
So bctx ran on great news from mastiatic breast cancer stock ran then bam came the public offering bctxl warrants expiring in 2031 already trading over 1$ so are shorts still trapped like ai is saying? Before the offering there was high si and cost to borrow almost 200% with …
$REVB: Major FDA Win: Single Study Pathway for Gemini (AKI) Approved 🚀
Ticker: REVB (Revelation Biosciences) Sector: Biotech / Renal Health Current Price (PM): \~$1.18 (+38% spike) The Catalyst: Why is it moving? Revelation Biosciences just dropped a massive PR announcing they have reached an agreement with the FDA on a simplified approval pathway for their lead candidate, Gemini, for treating Acute …